Guardant Health affiliate files to sell 2,000 shares

Guardant Health, Inc. affiliate filed a Form 144 reporting the proposed sale of 2,000 shares of common stock on 06/24/2026 associated with an employee stock option exercise and a broker payment for a cashless exercise.

Rhea-AI Filing Summary

Guardant Health, Inc. affiliate filed a Form 144 reporting the proposed sale of 2,000 shares of common stock on 06/24/2026 associated with an employee stock option exercise and a broker payment for a cashless exercise. The filing also lists prior sales by Meghan V. Joyce of 10,000 shares on 06/03/2026 for $1,269,809.00 and 6,203 shares on 06/22/2026 for $812,604.00. Shares outstanding are shown as 132,599,929 as of 06/24/2026.

Insights

Securities Compliance Counsel

Routine Form 144 notice for a cashless option exercise and small resale.

The filing records a proposed sale of 2,000 common shares tied to an employee stock option exercise with proceeds handled via a broker payment for cashless exercise. The action is procedural: Form 144 notifies the market of an intended resale by an affiliate on 06/24/2026.

Prior reported dispositions by Meghan V. Joyce (10,000 shares on 06/03/2026 for $1,269,809.00 and 6,203 shares on 06/22/2026 for $812,604.00) appear in the same excerpt. Cash‑flow treatment and whether sales were executed pursuant to any plan are not stated in the provided text.

Key Figures

Proposed resale: 2,000 shares Prior sale 1: 10,000 shares Prior sale 2: 6,203 shares +1 more

4 metrics

Proposed resale 2,000 shares Proposed sale on 06/24/2026 via cashless exercise

Prior sale 1 10,000 shares Sold on 06/03/2026 for $1,269,809.00

Prior sale 2 6,203 shares Sold on 06/22/2026 for $812,604.00

Shares outstanding 132,599,929 As of 06/24/2026

Key Terms

Employee Stock Option Exercise, Broker Payment for Cashless Exercise, Form 144

3 terms

Employee Stock Option Exercise financial

"Securities To Be Sold line showing method of disposition"

Broker Payment for Cashless Exercise financial

"Securities To Be Sold indicates settlement as broker payment"

Form 144 regulatory

"Header and filing type shown in the excerpt"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Guardant Health's (GH) Form 144 report?

The Form 144 reports a proposed resale of 2,000 common shares tied to an employee stock option exercise and settled via a broker payment for cashless exercise on 06/24/2026. It also lists two prior sales by Meghan V. Joyce.

Who reported prior sales in the filing for GH?

The filing lists prior dispositions by Meghan V. Joyce: 10,000 shares sold on 06/03/2026 for $1,269,809.00 and 6,203 shares sold on 06/22/2026 for $812,604.00. These are included in the excerpt.

Was the Form 144 sale executed or proposed for GH?

The record shows a Form 144 notice for a proposed sale of 2,000 shares on 06/24/2026 associated with a cashless exercise. The excerpt describes the proposed sale method but does not state settlement confirmation.

How many Guardant Health shares were outstanding per the excerpt?

The excerpt shows 132,599,929 shares outstanding as of 06/24/2026. That figure is presented in the filing text and serves as a baseline context in the same excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2026 - 04:02 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001770749
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Guardant Health, Inc.
SEC File Number	001-38683
Address of Issuer	3100 HANOVER STREET PALO ALTO CALIFORNIA 94304
Phone	855-698-8887
Name of Person for Whose Account the Securities are To Be Sold	Joyce Meghan V.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2000	280045.00	132599929	06/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/24/2026	Employee Stock Option Exercise	GUARDANT HEALTH, INC.			2000	06/24/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/03/2026	10000	1269809.00
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/22/2026	6203	812604.00

144: Remarks and Signature

Remarks
Date of Notice	06/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Meghan V. Joyce
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)